论文部分内容阅读
青霉素产量居亚洲第一座落在河北省石家庄市的中国特大型医药生产联合企业——华北制药股份有限公司,是由华北制药厂投入其全部生产经营性资产,并经募股于1992年组建的股份制企业。1994年初,华药股票在上海证券交易所挂牌上市,成为河北省首批上市公司之一。华北制药股份有限公司是我国目前最大的抗生素生产基地,现有员工1万余人,1995年末总资产21.78亿元,总股本772228760股。其中国家股占63.68%,社会公众股占36.32%。主要产品有青霉素、链霉素、四环素、林可霉素、半合抗青霉素,普鲁卡因青霉素、头孢菌素等多种抗生素原料药、制剂及维生素C、维生素B_(12),药用玻璃制品、有机溶剂、淀粉、葡萄糖等近百个品种,其抗生
Penicillin production ranks first in Asia Shijiazhuang City, Hebei Province, China’s largest pharmaceutical manufacturing conglomerate - North China Pharmaceutical Co., Ltd., is invested by North China Pharmaceutical Factory all its production and operation of assets, and after the formation of shares in 1992 Joint-stock enterprises. In early 1994, Huayao shares were listed on the Shanghai Stock Exchange and became one of the first listed companies in Hebei Province. North China Pharmaceutical Co., Ltd. is China’s largest antibiotic production base, the existing staff of more than 10,000 people, the total assets of 2.178 billion yuan at the end of 1995, the total share capital of 77,228,760 shares. Among them, state shares accounted for 63.68% and public shares accounted for 36.32%. The main products are penicillin, streptomycin, tetracycline, lincomycin, semi-resistant penicillin, procaine penicillin, cephalosporins and other antibiotics bulk drugs, preparations and vitamin C, vitamin B 12, medicinal Glass products, organic solvents, starch, glucose and other nearly 100 varieties of its antibiotic